世界の抗腫瘍性抗生物質市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP06799)
◆英語タイトル:Global Antitumor Antibiotics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP06799
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:101
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、抗腫瘍性抗生物質の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗腫瘍性抗生物質の種類別市場規模(エトポシド、ドキソルビシン、ダウノルビシン、ブレオマイシンA5)、用途別市場規模(乳癌、甲状腺癌、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Shyndec Pharmaceutical、Teva Pharmaceutical、KPC Pharmaceuticals、Qilu Antibiotics、Accord Healthcare、Gansu Fuzheng、Johnson & Johnson、Nippon Kayaku、China Resources Double Crane Pharmaceutical、Mylan、Pfizer、Sun Pharmaceutical、Cadila Pharmaceuticals
・地域別グローバル市場分析 2015年-2020年
・抗腫瘍性抗生物質の北米市場(アメリカ、カナダ、メキシコ)
・抗腫瘍性抗生物質のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・抗腫瘍性抗生物質のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・抗腫瘍性抗生物質の南米市場(ブラジル、アルゼンチン)
・抗腫瘍性抗生物質の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:エトポシド、ドキソルビシン、ダウノルビシン、ブレオマイシンA5
・用途別分析:乳癌、甲状腺癌、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Antitumor Antibiotics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Antitumor Antibiotics sales will be xx in 2020 from Antitumor Antibiotics million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Antitumor Antibiotics market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Antitumor Antibiotics industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Antitumor Antibiotics and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Antitumor Antibiotics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Antitumor Antibiotics market has been segmented into:
Etoposide
Doxorubicin
Daunorubicin
Bleomycin A5

By Application, Antitumor Antibiotics has been segmented into:
Breast Cancer
Thyroid Cancer
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antitumor Antibiotics market presented in the report. This section sheds light on the sales growth of different regional and country-level Antitumor Antibiotics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antitumor Antibiotics market.

The report offers in-depth assessment of the growth and other aspects of the Antitumor Antibiotics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Antitumor Antibiotics Market Share Analysis
Antitumor Antibiotics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antitumor Antibiotics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antitumor Antibiotics sales, revenue and market share for each player covered in this report.

The major players covered in Antitumor Antibiotics are:
Shyndec Pharmaceutical
Teva Pharmaceutical
KPC Pharmaceuticals
Qilu Antibiotics
Accord Healthcare
Gansu Fuzheng
Johnson & Johnson
Nippon Kayaku
China Resources Double Crane Pharmaceutical
Mylan
Pfizer
Sun Pharmaceutical
Cadila Pharmaceuticals
Among other players domestic and global, Antitumor Antibiotics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Antitumor Antibiotics Market Overview
1.1 Product Overview and Scope of Antitumor Antibiotics
1.2 Classification of Antitumor Antibiotics by Type
1.2.1 Global Antitumor Antibiotics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Antitumor Antibiotics Revenue Market Share by Type in 2019
1.2.3 Etoposide
1.2.4 Doxorubicin
1.2.5 Daunorubicin
1.2.6 Bleomycin A5
1.3 Global Antitumor Antibiotics Market by Application
1.3.1 Overview: Global Antitumor Antibiotics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Thyroid Cancer
1.3.4 Others
1.4 Global Antitumor Antibiotics Market by Regions
1.4.1 Global Antitumor Antibiotics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Antitumor Antibiotics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Antitumor Antibiotics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Antitumor Antibiotics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antitumor Antibiotics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Antitumor Antibiotics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antitumor Antibiotics Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Antitumor Antibiotics Industry Impact
1.5.1 COVID-19 Potential Implications for the Antitumor Antibiotics
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Antitumor Antibiotics
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Shyndec Pharmaceutical
2.1.1 Shyndec Pharmaceutical Details
2.1.2 Shyndec Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Shyndec Pharmaceutical SWOT Analysis
2.1.4 Shyndec Pharmaceutical Product and Services
2.1.5 Shyndec Pharmaceutical Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teva Pharmaceutical
2.2.1 Teva Pharmaceutical Details
2.2.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teva Pharmaceutical SWOT Analysis
2.2.4 Teva Pharmaceutical Product and Services
2.2.5 Teva Pharmaceutical Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.3 KPC Pharmaceuticals
2.3.1 KPC Pharmaceuticals Details
2.3.2 KPC Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 KPC Pharmaceuticals SWOT Analysis
2.3.4 KPC Pharmaceuticals Product and Services
2.3.5 KPC Pharmaceuticals Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Qilu Antibiotics
2.4.1 Qilu Antibiotics Details
2.4.2 Qilu Antibiotics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Qilu Antibiotics SWOT Analysis
2.4.4 Qilu Antibiotics Product and Services
2.4.5 Qilu Antibiotics Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Accord Healthcare
2.5.1 Accord Healthcare Details
2.5.2 Accord Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Accord Healthcare SWOT Analysis
2.5.4 Accord Healthcare Product and Services
2.5.5 Accord Healthcare Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Gansu Fuzheng
2.6.1 Gansu Fuzheng Details
2.6.2 Gansu Fuzheng Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Gansu Fuzheng SWOT Analysis
2.6.4 Gansu Fuzheng Product and Services
2.6.5 Gansu Fuzheng Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Johnson & Johnson SWOT Analysis
2.7.4 Johnson & Johnson Product and Services
2.7.5 Johnson & Johnson Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Nippon Kayaku
2.8.1 Nippon Kayaku Details
2.8.2 Nippon Kayaku Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Nippon Kayaku SWOT Analysis
2.8.4 Nippon Kayaku Product and Services
2.8.5 Nippon Kayaku Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.9 China Resources Double Crane Pharmaceutical
2.9.1 China Resources Double Crane Pharmaceutical Details
2.9.2 China Resources Double Crane Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 China Resources Double Crane Pharmaceutical SWOT Analysis
2.9.4 China Resources Double Crane Pharmaceutical Product and Services
2.9.5 China Resources Double Crane Pharmaceutical Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mylan SWOT Analysis
2.10.4 Mylan Product and Services
2.10.5 Mylan Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pfizer SWOT Analysis
2.11.4 Pfizer Product and Services
2.11.5 Pfizer Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sun Pharmaceutical
2.12.1 Sun Pharmaceutical Details
2.12.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sun Pharmaceutical SWOT Analysis
2.12.4 Sun Pharmaceutical Product and Services
2.12.5 Sun Pharmaceutical Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Cadila Pharmaceuticals
2.13.1 Cadila Pharmaceuticals Details
2.13.2 Cadila Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Cadila Pharmaceuticals SWOT Analysis
2.13.4 Cadila Pharmaceuticals Product and Services
2.13.5 Cadila Pharmaceuticals Antitumor Antibiotics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Antitumor Antibiotics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Antitumor Antibiotics Players Market Share
3.2.2 Top 10 Antitumor Antibiotics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Antitumor Antibiotics Revenue and Market Share by Regions
4.2 North America Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
4.3 Europe Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
4.5 South America Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
5 North America Antitumor Antibiotics Revenue by Countries
5.1 North America Antitumor Antibiotics Revenue by Countries (2015-2020)
5.2 USA Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
5.3 Canada Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
5.4 Mexico Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
6 Europe Antitumor Antibiotics Revenue by Countries
6.1 Europe Antitumor Antibiotics Revenue by Countries (2015-2020)
6.2 Germany Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
6.3 UK Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
6.4 France Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
6.5 Russia Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
6.6 Italy Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antitumor Antibiotics Revenue by Countries
7.1 Asia-Pacific Antitumor Antibiotics Revenue by Countries (2015-2020)
7.2 China Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
7.3 Japan Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
7.4 Korea Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
7.5 India Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
8 South America Antitumor Antibiotics Revenue by Countries
8.1 South America Antitumor Antibiotics Revenue by Countries (2015-2020)
8.2 Brazil Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
8.3 Argentina Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antitumor Antibiotics by Countries
9.1 Middle East & Africa Antitumor Antibiotics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
9.3 UAE Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
9.4 Egypt Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
9.5 South Africa Antitumor Antibiotics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Antitumor Antibiotics Revenue and Market Share by Type (2015-2020)
10.2 Global Antitumor Antibiotics Market Forecast by Type (2019-2024)
10.3 Etoposide Revenue Growth Rate (2015-2025)
10.4 Doxorubicin Revenue Growth Rate (2015-2025)
10.5 Daunorubicin Revenue Growth Rate (2015-2025)
10.6 Bleomycin A5 Revenue Growth Rate (2015-2025)
11 Global Antitumor Antibiotics Market Segment by Application
11.1 Global Antitumor Antibiotics Revenue Market Share by Application (2015-2020)
11.2 Antitumor Antibiotics Market Forecast by Application (2019-2024)
11.3 Breast Cancer Revenue Growth (2015-2020)
11.4 Thyroid Cancer Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Antitumor Antibiotics Market Size Forecast (2021-2025)
12.1 Global Antitumor Antibiotics Market Size Forecast (2021-2025)
12.2 Global Antitumor Antibiotics Market Forecast by Regions (2021-2025)
12.3 North America Antitumor Antibiotics Revenue Market Forecast (2021-2025)
12.4 Europe Antitumor Antibiotics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Antitumor Antibiotics Revenue Market Forecast (2021-2025)
12.6 South America Antitumor Antibiotics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Antitumor Antibiotics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Shyndec Pharmaceutical、Teva Pharmaceutical、KPC Pharmaceuticals、Qilu Antibiotics、Accord Healthcare、Gansu Fuzheng、Johnson & Johnson、Nippon Kayaku、China Resources Double Crane Pharmaceutical、Mylan、Pfizer、Sun Pharmaceutical、Cadila Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の抗腫瘍性抗生物質市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Antitumor Antibiotics Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。